» Articles » PMID: 33526036

LncRNA MEG8 Promotes NSCLC Progression by Modulating the MiR-15a-5p-miR-15b-5p/PSAT1 Axis

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2021 Feb 2
PMID 33526036
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Non-small cell lung cancer (NSCLC) is the most common tumor with severe morbidity and high mortality. Long non-coding RNAs (lncRNAs) as crucial regulators participate in multiple cancer progressions. However, the role of lncRNA MEG8 in the development of NSCLC remains unclear. Here, we aimed to investigate the effect of lncRNA MEG8 on the progression of NSCLC and the underlying mechanism.

Methods: Cell proliferation was analyzed by EdU assays. The impacts of lncRNA MEG8, miR-15a-5p, and miR-15b-5p on cell invasion and migration of NSCLC were assessed by transwell assay. The luciferase reporter gene assay was performed using the Dual-luciferase Reporter Assay System. The effect of lncRNA MEG8, miR-15a-5p, and miR-15b-5p on tumor growth was evaluated in nude mice of Balb/c in vivo.

Results: We revealed that the expression levels of MEG8 were elevated in the NSCLC patient tissues compared to that in adjacent normal tissues. The expression of MEG8 was negatively relative to that of miR-15a-5p and miR-15b-5p in the NSCLC patient tissues. The expression of MEG8 was upregulated, while miR-15a-5p and miR-15b-5p were downregulated in NSCLC cell lines. The depletion of MEG8 inhibited NSCLC cell proliferation, migration, and invasion in vitro. MEG8 contributed to NSCLC progression by targeting miR-15a-5p/miR-15b-5p in vitro. LncRNA MEG8 contributes to tumor growth of NSCLC via the miR-15a/b-5p/PSAT1 axis in vivo. Thus, we concluded that lncRNA MEG8 promotes NSCLC progression by modulating the miR-15a/b-5p/PSAT1 axis.

Conclusions: Our findings demonstrated that lncRNA MEG8 plays a critical role in NSCLC development. LncRNA MEG8, miR-15a-5p, miR-15b-5p, and PSAT1 may serve as potential targets for NSCLC therapy.

Citing Articles

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.

Jiao J, Zhao Y, Li Q, Jin S, Liu Z Front Immunol. 2024; 15:1467151.

PMID: 39539540 PMC: 11557318. DOI: 10.3389/fimmu.2024.1467151.


sponges to promote hypopharyngeal squamous cell carcinoma progression by facilitating cancer stem cell-like phenotypes.

Zhang B, Ye Q J Cancer. 2024; 15(12):3781-3793.

PMID: 38911389 PMC: 11190759. DOI: 10.7150/jca.95852.


Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics.

Padinharayil H, Varghese J, John M, Rajanikant G, Wilson C, Al-Yozbaki M Genes Dis. 2023; 10(3):960-989.

PMID: 37396553 PMC: 10308181. DOI: 10.1016/j.gendis.2022.07.023.


Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers.

Sun W, Liu R, Gao X, Lin Z, Tang H, Cui H Biomark Res. 2023; 11(1):48.

PMID: 37147729 PMC: 10161514. DOI: 10.1186/s40364-023-00487-4.


Amino acid metabolism regulated by lncRNAs: the propellant behind cancer metabolic reprogramming.

Hu Q, Li Y, Li D, Yuan Y, Wang K, Yao L Cell Commun Signal. 2023; 21(1):87.

PMID: 37127605 PMC: 10152737. DOI: 10.1186/s12964-023-01116-1.


References
1.
Hagan J, ONeill B, Stewart C, Kozlov S, Croce C . At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1. PLoS One. 2009; 4(2):e4352. PMC: 2632752. DOI: 10.1371/journal.pone.0004352. View

2.
Metcalf S, Dougherty S, Kruer T, Hasan N, Biyik-Sit R, Reynolds L . Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer. Clin Exp Metastasis. 2019; 37(1):187-197. DOI: 10.1007/s10585-019-10000-7. View

3.
Kontos C, Tsiakanikas P, Avgeris M, Papadopoulos I, Scorilas A . miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma. Mol Diagn Ther. 2017; 21(4):453-464. DOI: 10.1007/s40291-017-0270-3. View

4.
Zhou X, Zhang Z, Liang X . Regulatory Network Analysis to Reveal Important miRNAs and Genes in Non-Small Cell Lung Cancer. Cell J. 2019; 21(4):459-466. PMC: 6722447. DOI: 10.22074/cellj.2020.6281. View

5.
Terashima M, Ishimura A, Wanna-Udom S, Suzuki T . long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells. J Biol Chem. 2018; 293(47):18016-18030. PMC: 6254362. DOI: 10.1074/jbc.RA118.004006. View